Joel Lexchin

Showing all 4 results

Title & Subtitle Abstract Contributors Pages Year Purchase
From

The TPP and the Regulation of Medicines in Canada

From: The Trans-Pacific Partnership and Canada

Preview

Explores the implications of the TPP for drug costs resulting from the agreement’s provisions on intellectual property, services and investment. 18 $1.80 Add
From
NEW!

Pharmaceutical Companies

Relationship Between the Canadian Government and Big Pharma — “Clientele Pluralism”

From: Corporate Rules

Preview

In this chapter, Joel Lexchin examines the pharmaceutical industry and “clientele pluralism. “ Lexchin argues that the pharmaceutical industry can drive regulation by influencing not … 20 $2.00 Add
From

Obsessed by Profits: Big Pharma and the Corruption of Health

From: Oppression

Preview

This chapter starts with an overall description of Big Pharma, goes on to discuss the consequences of drug companies’ overriding objective of increasing sales in order to increase profits, … 17 $1.70 Add
From

Pharmacare:

Equity, Efficiency, and Effectiveness — We’ve Waited Long Enough.

From: Medicare

Preview

Analyzes the debate about pharmacare by noting the similarity between how we fund perscription drugs and the way America funds their entire health care system and notes our rejection of this … 8 $0.80 Add